What is the Clinical Institute Withdrawal Assessment (CIWA) scoring system for assessing alcohol withdrawal in patients with a history of alcohol use?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

CIWA Scoring System

The Clinical Institute Withdrawal Assessment for Alcohol (CIWA) is a standardized scoring tool that evaluates the severity of alcohol withdrawal syndrome by assessing 10 symptoms, with scores ≥8 indicating moderate withdrawal requiring benzodiazepine treatment and scores ≥15 indicating severe withdrawal with higher risk of complications. 1

What CIWA Measures

The CIWA assessment quantifies symptoms across three main categories:

  • Autonomic nervous system activation including tremor, sweating, and elevated vital signs 1
  • Gastrointestinal symptoms such as nausea and vomiting 1
  • Cognitive deficits including orientation, agitation, and hallucinations 1

The scale generates a numerical score that directly correlates with withdrawal severity, with higher scores predicting increased risk of complications like seizures and delirium tremens 2

Treatment Thresholds Based on CIWA Scores

CIWA scores provide clear action points for medication administration:

  • Scores <8: Mild withdrawal, typically managed with supportive care and thiamine supplementation 3
  • Scores 8-14: Moderate withdrawal requiring benzodiazepine intervention, typically diazepam 5-10mg every 6-8 hours 1
  • Scores ≥15: Severe withdrawal necessitating aggressive benzodiazepine dosing and close monitoring 1, 3

Research demonstrates that patients scoring >15 have a 3.72-fold increased risk of severe withdrawal complications if left untreated 2. Patients with scores ≥10 at admission have a 46.6% risk of progressing to delirium tremens compared to only 2.8% in those with lower scores 4

Clinical Application and Monitoring

Use CIWA for symptom-triggered benzodiazepine dosing rather than fixed-schedule administration to prevent medication accumulation and reduce total benzodiazepine exposure 3. This approach has been shown to decrease mean diazepam doses from 81.4mg to 60.3mg without increasing complications 5

Assess CIWA scores:

  • Every 1-2 hours during acute withdrawal (first 24-48 hours) 3
  • Every 4-6 hours as symptoms stabilize 3
  • Continue monitoring for 3-5 days after last drink, as withdrawal symptoms peak during this period 1, 6

Critical Limitations and Pitfalls

CIWA should NOT be used alone for diagnosing alcohol withdrawal syndrome 1, 3. High CIWA scores can occur in multiple conditions that mimic AWS:

  • Anxiolytic or benzodiazepine withdrawal 1
  • Anxiety disorders 1, 3
  • Sepsis or systemic infection 1, 3
  • Hepatic encephalopathy 1, 3
  • Severe pain 1

Many CIWA items rely on subjective patient reporting, making the scale time-consuming and potentially unreliable in certain populations 5. Recent research shows CIWA scores have poor predictive value for identifying patients who will progress to requiring ICU-level care, with a sensitivity of only 12% at the optimal cutoff of 24 7

Essential Adjunctive Measures

Regardless of CIWA score, ALL patients with alcohol withdrawal must receive:

  • Thiamine 100-300mg daily administered BEFORE any glucose-containing fluids to prevent Wernicke encephalopathy 1, 6, 3
  • Continued thiamine supplementation for 2-3 months following withdrawal resolution 1, 6, 3
  • Fluid and electrolyte replacement with particular attention to magnesium levels 6
  • Psychiatric consultation for evaluation and long-term abstinence planning after stabilization 1, 3

References

Guideline

CIWA Scoring for Alcohol Withdrawal Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Alcohol Withdrawal Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

A new rating scale for the assessment of the alcohol-withdrawal syndrome (AWS scale).

Alcohol and alcoholism (Oxford, Oxfordshire), 1997

Guideline

Management of Severe Alcohol Withdrawal

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What are the components of the Clinical Institute Withdrawal Assessment (CIWA) score?
How is the Clinical Institute Withdrawal Assessment (CIWA) scored in patients undergoing alcohol or benzodiazepine withdrawal?
What is the initial step in managing alcohol withdrawal using the Clinical Institute Withdrawal Assessment (CIWA) protocol?
How is the CIWA (Clinical Institute Withdrawal Assessment) scoring system used to guide treatment decisions for alcohol withdrawal symptoms?
What is the protocol for managing alcohol withdrawal in a patient using the Clinical Institute Withdrawal Assessment (CIWA) scale?
What is the simple formula to calculate half-life (t1/2) of a substance in a patient with potential renal or hepatic impairment?
Are NSAIDs (Non-Steroidal Anti-Inflammatory Drugs) contraindicated in older adults with acute decompensated heart failure, particularly those with comorbidities such as hypertension, diabetes, and chronic kidney disease?
What is the best course of action for a 34-week gestation pregnant individual with ruptured membranes (Ruptured Membranes) for 6 hours, who is stable, has no uterine contractions, and has meconium-stained liquor (Meconium-Stained Amniotic Fluid)?
Can a patient who is currently taking Prestiq (desvenlafaxine) 50 mg daily add Wellbutrin (bupropion) to their treatment regimen?
What is the most likely diagnosis for a female patient of reproductive age with a history of infertility, presenting with severe dysmenorrhea unrelieved by naproxen (nonsteroidal anti-inflammatory drug)?
What is the initial management for a patient with congestive heart failure (CHF)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.